NEW YORK (
) hit a new 52-week high Wednesday as it is currently trading at $44.77, above its previous 52-week high of $44.73 with 12,357 shares traded as of 11:12 a.m. ET. Average volume has been 100,600 shares over the past 30 days.
Balchem has a market cap of $1.3 billion and is part of the
industry. Shares are up 29.5% year to date as of the close of trading on Tuesday.
Balchem Corporation engages in the development, manufacture, and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, and medical sterilization industries in the United States and internationally. The company has a P/E ratio of 37.1, equal to the average food & beverage industry P/E ratio and above the S&P 500 P/E ratio of 17.7.
- Practice your BCPC trading strategies and win cash in our stock game.
TheStreet Ratings rates Balchem as a
. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and compelling growth in net income. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. You can view the full
52-week high stocks
or get investment ideas from our